Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Cardiovascular Disease
100%
Injury
50%
Atherosclerosis
50%
Congestive Heart Failure
50%
Heart Ventricle Hypertrophy
50%
Shock
50%
Myocardial Ischemia Reperfusion Injury
50%
Vascular Remodeling
50%
Myocardial Disease
50%
Malignant Neoplasm
25%
Reactive Oxygen Metabolite
25%
Vitamin D
25%
Purine Derivative
25%
Therapeutic Effect
25%
Knockout Mouse
25%
Diabetic Complication
25%
Adenosine Triphosphate
25%
Reactive Nitrogen Species
25%
Anticarcinogen
25%
Functional Disease
25%
Polyamine
25%
Thyroid Hormone
25%
Keyphrases
Cardiovascular Disease
100%
Therapeutic Potential
100%
PARP Inhibitor (PARPi)
100%
Cardiomyopathy
25%
Endothelial Cells
25%
Cardiomyocytes
25%
Circulatory Shock
25%
Myocardial Hypertrophy
25%
Cardiovascular Aging
25%
Angiogenesis
25%
Heart Failure
25%
Myocardial Ischemia-reperfusion Injury
25%
Vascular Remodeling
25%
Cancer Treatment
12%
Knock-in Mouse Model
12%
Reactive Oxygen Species
12%
Vitamin D
12%
Purine
12%
Estrogen
12%
Pharmacological Inhibitors
12%
Therapeutic Effect
12%
Diabetes Complications
12%
Diabetic Vascular Complications
12%
Reactive Species
12%
Glycolysis
12%
Reactive Nitrogen Species
12%
Inflammatory Pathways
12%
Anticancer Drugs
12%
Thyroid Hormones
12%
Oxidative DNA Damage
12%
Nicotinamide Adenine Dinucleotide (NAD+)
12%
Functional Impairment
12%
Electron Transport
12%
PARP Activation
12%
Endogenous Factors
12%
Polyamines
12%
Overactivation
12%
Significant Benefit
12%
Clinical Development
12%
ATP Formation
12%
Enzyme Family
12%
PARP Enzymes
12%